Clinical Trial Update: Rudi Kundini, Pamoja Kundini: Phase I [NA]

View source ↗

Summary

Phase I clinical trial evaluating Rudi Kundini and Pamoja Kundini for HIV has completed, sponsored by the University of California, Berkeley.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Pamoja Kundini
• Rudi Kundini

Snippet

Sponsor: University of California, Berkeley | Conditions: HIV (Human Immunodeficiency Virus) | NA | Status: COMPLETED